Roquefort Therapeutics (LON:ROQ) Trading Down 7.1% – Time to Sell?

Roquefort Therapeutics plc (LON:ROQ)’s share price fell 7.1% during trading on Friday . The stock traded as low as GBX 5 ($0.06) and last traded at GBX 5.20 ($0.07). 2,808,162 shares were traded during trading, an increase of 639% from the average session volume of 379,845 shares. The stock had previously closed at GBX 5.60 ($0.07).

Roquefort Therapeutics Stock Performance

The company has a current ratio of 0.79, a quick ratio of 3.07 and a debt-to-equity ratio of 12.37. The company has a market cap of £6.62 million, a price-to-earnings ratio of -512.80 and a beta of 0.05. The stock has a 50 day moving average price of GBX 3.78 and a two-hundred day moving average price of GBX 4.25.

About Roquefort Therapeutics

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.